4.7 Article

Augmenter of liver regeneration protects the kidney against ischemia-reperfusion injury by inhibiting necroptosis

Journal

BIOENGINEERED
Volume 13, Issue 3, Pages 5152-5167

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/21655979.2022.2037248

Keywords

Augmenter of liver regeneration; kidney; hypoxia reoxygenation; ischemia-reperfusion; necroptosis

Funding

  1. National Natural Science Foundation of China [81,873,604, 81,000,299]
  2. Chongqing Overseas Students Entrepreneurship Innovation Support Program [cx2018038]
  3. Natural Science Foundation Project of CQ CSTC [cstc2019jscx-msxm0157, cstc2015jcyjA10069]
  4. Fourth Batch of Chongqing Young and Middle-Aged Medical High-end Reserve Talent Fund [(2018) 230]
  5. Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University

Ask authors/readers for more resources

This study demonstrates the important role of augmenter of liver regeneration (ALR) in acute kidney injury (AKI) and its inhibitory effect on necroptosis caused by ischemia-reperfusion. ALR overexpression reduces the expression of injury molecules and inflammation-associated factors, as well as inhibits the expression of necroptosis-related proteins. These findings suggest that ALR has a protective effect against AKI and regulate necroptosis.
Necroptosis plays an important role in the pathogenesis of acute kidney injury (AKI), and necroptosis-related interventions may therefore be an important measure for the treatment of AKI. Our previous study has shown that augmenter of liver regeneration (ALR) inhibits renal tubular epithelial cell apoptosis and regulates autophagy; however, the influence of ALR on necroptosis remains unclear. In this study, we investigated the effect of ALR on necroptosis caused by ischemia-reperfusion and the underlying mechanism. In vivo experiments indicated that kidney-specific knockout of ALR aggravated the renal dysfunction and pathological damage induced by ischemia-reperfusion. Simultaneously, the expression of renal necroptosis-associated protein receptor-interacting protein 1 (RIP1), receptor-interacting protein 3 (RIP3), and mixed-lineage kinase domain-like protein (MLKL) significantly increased. In vitro experiments indicated that overexpression of ALR decreased the expression of hypoxia-reoxygenation-induced kidney injury molecules, the inflammation-associated factor tumor necrosis factor-alpha (TNF-alpha), and monocyte chemotactic protein. Additionally, the expression of RIP1, RIP3, and MLKL, which are elevated after hypoxia and reoxygenation, was also inhibited by ALR overexpression. Both in vivo and in vitro results indicated that ALR has a protective effect against acute kidney injury caused by ischemia-reperfusion, and the RIP1/RIP3/MLKL pathway should be further verified as a probable necroptosis regulating mechanism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available